Effects of aqueous polymeric surfactants on silicone-hydrogel soft- contact-lens wettability and bacterial adhesion of Pseudomonas aeruginosa.
Victoria B Tran, Ye Suel Sung, Kendra Copley, C J Radke, Victoria B. Tran, Ye Suel Sung, Kendra Copley, C.J. Radke
Index: Cont. Lens Anterior Eye 35(4) , 155-62, (2012)
Full Text: HTML
Abstract
Prevention of Pseudomonas aeruginosa binding to soft-contact lenses (SCLs) may curtail sight-threatening microbial keratitis. Substrate surface wettability is known to modulate adhesion of P. aeruginosa. This study investigates the use of aqueous alkoxylate block co-polymer surfactants for enhanced wettability and antibacterial adhesion of SCLs under leaching conditions. Specifically, Pluronic(®) F127 (PF) and three ethylene oxide-butylene oxide (EOBO) surfactants were studied with four commercially available silicone-hydrogel contact lenses: Pure Vision™, Acuvue Advance™, Acuvue Oasys™ and O(2)Optix™. Dilute aqueous PF and EOBO surfactants impregnated all four soft-contact lenses, as demonstrated by surface-tension decline for leached surfactant. For PF surfactant, significant surface-wettability improvement upon rinsing occurred only after overnight leaching. EOBO surfactant showed a similar pattern with O(2)Optix™ lenses. EOBO-pretreated Pure Vision™ lenses, however, showed fast leaching and a significant change in surface energy towards improved wettability. Adhesion assays of P. aeruginosa displayed a small decrease in the binding rate of PAK bacteria for EOBO-pretreated Pure Vision™ lenses, but not for EOBO-pretreated O(2)Optix™ lenses. P. aeruginosa strain-PAO1 bacteria adhesion to all lenses was independent of surface wettability. Despite the ability of polymeric surfactants to lower advancing contact angles under leaching conditions, increased lens wettability is not a universal panacea for antifouling of soft-contact lenses.Copyright © 2012 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2006-04-15
[Anal. Chem. 78(8) , 2608-2616, (2006)]
1993-09-01
[Mutagenesis 8(5) , 387-93, (1993)]
1999-09-01
[Clin. Neurol. Neurosurg. 101(3) , 199-202, (1999)]
1984-01-01
[J. Cancer Res. Clin. Oncol. 107(3) , 149-56, (1984)]
2009-01-01
[Int. J. Pharm. 369(1-2) , 196-8, (2009)]